BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20669041)

  • 1. The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model.
    Yu J; Lee HJ; Hur K; Kwak MK; Han TS; Kim WH; Song SC; Yanagihara K; Yang HK
    Invest New Drugs; 2012 Feb; 30(1):1-7. PubMed ID: 20669041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermosensitive hydrogel system assembled by PTX-loaded copolymer nanoparticles for sustained intraperitoneal chemotherapy of peritoneal carcinomatosis.
    Xu S; Fan H; Yin L; Zhang J; Dong A; Deng L; Tang H
    Eur J Pharm Biopharm; 2016 Jul; 104():251-9. PubMed ID: 27185379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral delivery of paclitaxel using a thermosensitive hydrogel in human tumor xenografts.
    Kim JH; Lee JH; Kim KS; Na K; Song SC; Lee J; Kuh HJ
    Arch Pharm Res; 2013 Jan; 36(1):94-101. PubMed ID: 23371803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites.
    Gong C; Wang C; Wang Y; Wu Q; Zhang D; Luo F; Qian Z
    Nanoscale; 2012 May; 4(10):3095-104. PubMed ID: 22535210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice.
    Ohashi N; Kodera Y; Nakanishi H; Yokoyama H; Fujiwara M; Koike M; Hibi K; Nakao A; Tatematsu M
    Int J Oncol; 2005 Sep; 27(3):637-44. PubMed ID: 16077911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer.
    De Clercq K; Xie F; De Wever O; Descamps B; Hoorens A; Vermeulen A; Ceelen W; Vervaet C
    Sci Rep; 2019 Oct; 9(1):14881. PubMed ID: 31619730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect and pharmacokinetics of intraperitoneal NK105, a nanomicellar paclitaxel formulation for peritoneal dissemination.
    Emoto S; Yamaguchi H; Kishikawa J; Yamashita H; Ishigami H; Kitayama J
    Cancer Sci; 2012 Jul; 103(7):1304-10. PubMed ID: 22429777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-Loaded Polymersomes for Enhanced Intraperitoneal Chemotherapy.
    Simón-Gracia L; Hunt H; Scodeller PD; Gaitzsch J; Braun GB; Willmore AM; Ruoslahti E; Battaglia G; Teesalu T
    Mol Cancer Ther; 2016 Apr; 15(4):670-9. PubMed ID: 26880267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reconstituted thermosensitive hydrogel system based on paclitaxel-loaded amphiphilic copolymer nanoparticles and antitumor efficacy.
    Liang Y; Dong C; Zhang J; Deng L; Dong A
    Drug Dev Ind Pharm; 2017 Jun; 43(6):972-979. PubMed ID: 28121206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-peritoneal administration of paclitaxel with non-animal stabilized hyaluronic acid as a vehicle--a new strategy against peritoneal dissemination of gastric cancer.
    Yamada J; Kitayama J; Tsuno NH; Yamashita H; Miyato H; Soma D; Otani K; Kamei T; Ishigami H; Hidemura A; Kaisaki S; Takahashi K; Nagawa H
    Cancer Lett; 2008 Dec; 272(2):307-15. PubMed ID: 18768251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal administration of a small interfering RNA targeting nuclear factor-kappa B with paclitaxel successfully prolongs the survival of xenograft model mice with peritoneal metastasis of gastric cancer.
    Inoue M; Matsumoto S; Saito H; Tsujitani S; Ikeguchi M
    Int J Cancer; 2008 Dec; 123(11):2696-701. PubMed ID: 18798274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patient with gastric cancer with peritoneal carcinomatosis treated with intraperitoneal chemotherapy who survived more than 5 years receiving repeated laparoscopic examinations: a case report.
    Yamaguchi H; Kitayama J; Ishigami H; Emoto S; Nishikawa T; Tanaka J; Tanaka T; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kazama S; Ishihara S; Sunami E; Watanabe T
    J Med Case Rep; 2016 Jan; 10():14. PubMed ID: 26786355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo optical pathology of paclitaxel efficacy on the peritoneal metastatic xenograft model of gastric cancer using two-photon laser scanning microscopy.
    Shimura T; Tanaka K; Toiyama Y; Okigami M; Ide S; Kitajima T; Kondo S; Saigusa S; Ohi M; Araki T; Inoue Y; Uchida K; Mohri Y; Mizoguchi A; Kusunoki M
    Gastric Cancer; 2015 Jan; 18(1):109-18. PubMed ID: 24399494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal chemotherapy with hydroxycamptothecin reduces peritoneal carcinomatosis: results of an experimental study.
    Li PC; Chen LD; Zheng F; Li Y
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):37-44. PubMed ID: 17665213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal paclitaxel: a possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma.
    Kodera Y; Ito Y; Ito S; Ohashi N; Mochizuki Y; Yamamura Y; Koike M; Fujiwara M; Nakanishi H; Nakao A
    Hepatogastroenterology; 2007; 54(75):960-3. PubMed ID: 17591103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors.
    Wang J; Lu Z; Yeung BZ; Wientjes MG; Cole DJ; Au JL
    J Control Release; 2014 Mar; 178():79-85. PubMed ID: 24462901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camptothecine encapsulated composite drug delivery system for colorectal peritoneal carcinomatosis therapy: biodegradable microsphere in thermosensitive hydrogel.
    Liu L; Wu Q; Ma X; Xiong D; Gong C; Qian Z; Zhao X; Wei Y
    Colloids Surf B Biointerfaces; 2013 Jun; 106():93-101. PubMed ID: 23434697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proof-of-Concept of Polymeric Sol-Gels in Multi-Drug Delivery and Intraoperative Image-Guided Surgery for Peritoneal Ovarian Cancer.
    McKenzie M; Betts D; Suh A; Bui K; Tang R; Liang K; Achilefu S; Kwon GS; Cho H
    Pharm Res; 2016 Sep; 33(9):2298-306. PubMed ID: 27283829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer.
    Emoto S; Yamaguchi H; Kamei T; Ishigami H; Suhara T; Suzuki Y; Ito T; Kitayama J; Watanabe T
    Surg Today; 2014 May; 44(5):919-26. PubMed ID: 23887848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel.
    Hu H; Lin Z; He B; Dai W; Wang X; Wang J; Zhang X; Zhang H; Zhang Q
    J Control Release; 2015 Dec; 220(Pt A):189-200. PubMed ID: 26474677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.